Asset Management One Co., Ltd. Gilead Sciences, Inc. Transaction History
Asset Management One Co., Ltd.
- $27.7 Billion
- Q3 2024
A detailed history of Asset Management One Co., Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 664,864 shares of GILD stock, worth $60.8 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
664,864
Previous 652,847
1.84%
Holding current value
$60.8 Million
Previous $44.8 Million
24.42%
% of portfolio
0.2%
Previous 0.17%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
1,928Shares Held
992MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.5 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.65 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.5 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $115B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...